03.05.2013 Views

Optimalisatie van de werkingsprocessen van het Bijzonder ... - KCE

Optimalisatie van de werkingsprocessen van het Bijzonder ... - KCE

Optimalisatie van de werkingsprocessen van het Bijzonder ... - KCE

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>KCE</strong> Reports 133 Special Solidarity Fund 161<br />

9.11 RESULTS OF THE INTERVIEWS WITH THE PATIENT<br />

ORGANISATIONS<br />

9.11.1 Brief presentation of the interviewed patient organizations<br />

9.11.1.1 DEBRA<br />

Debra (Dystrophic Epi<strong>de</strong>rmolysis Bullosa Research Association) was foun<strong>de</strong>d in 1978 in<br />

the United Kingdom and as non-profit organization in Belgium in 1999.<br />

EB (Epi<strong>de</strong>rmolysis Bullosa), a rare disease, can broadly be classified into three main<br />

groups: EB simplex, junctional EB and dystrophic EB. The exact number of EB patients in<br />

Belgium is not known, since no registry of the disease exists. The annual number of<br />

patients born with EB is limited and many of these children die at a young age. The<br />

database of Debra Belgium contains +/- 80 records of patients or families confronted<br />

with EB.<br />

9.11.1.2 PH Belgium<br />

The patient organization "pulmonary hypertension" Belgium was foun<strong>de</strong>d in 2001. In<br />

2003, the organization joined the European Organization PHA Europe. The number of<br />

patients with PH (pulmonary hypertension) in Belgium is estimated around 350, the<br />

number of members of PH Belgium is situated around 150 people. PH is divi<strong>de</strong>d into 4<br />

classes (I,II,III,IV) according to NYHA (New York Heart Association) classification. The<br />

severity of the disease increases in ascending or<strong>de</strong>r. Class IV patients get their<br />

treatment (drugs) usually via an electronically controlled pump system.<br />

9.11.1.3 BOKS<br />

BOKS (Belgian organization for children and adults with metabolic disor<strong>de</strong>rs) was<br />

foun<strong>de</strong>d in 1994. This umbrella organization represents 1300 diseases, which are<br />

individually too rare to generate interest and support from the wi<strong>de</strong>r public. BOKS<br />

represents about 550 households, of which 450 children are confronted with a<br />

metabolic disor<strong>de</strong>r. 30 children are still waiting for the exact diagnosis of their disor<strong>de</strong>r,<br />

50 children died in the meantime. BOKS database inclu<strong>de</strong>s around 1000 records.<br />

9.11.1.4 NEMA<br />

NEMA, the Flemish patient organization for neuromuscular diseases was foun<strong>de</strong>d in<br />

1987. The members of this umbrella organization represent a wi<strong>de</strong> variety of<br />

approximately 50 neuromuscular disor<strong>de</strong>rs. Nema welcomes not only patients but also<br />

parents, family members, friends, professionals or other relatives. Thanks to their close<br />

cooperation with the neuromuscular reference centers (NMRC’s), there are able to<br />

keep their medical information up to date.<br />

9.11.1.5 Radiorg.be<br />

Radiorg.be (rare diseases organization Belgium), is foun<strong>de</strong>d in January 2008 and<br />

recognized by Eurordis as the Belgian Alliance for Rare diseases. Radiorg.be is an<br />

umbrella organization representing approximately 80 very specific rare disease patient<br />

organizations. Radiorg.be represents 6.5% of the Belgian population (65,000 people) of<br />

which approximately 75% are children. As the objectives of radiorg.be as an umbrella<br />

organization are quite different from the 4 other specific patient organizations on rare<br />

diseases, a separate paragraph is written on radiorg.be

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!